Related Experiment Video

Updated: Jun 25, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Role of the Akt pathway in prostate cancer

Paul L de Souza1, Pamela J Russell, John Kearsley

  • 1Cancer Pharmacology and Therapeutics Lab, St George Hospital Clinical School, Gray Street, Kogarah, NSW 2217, Australia. p.desouza@unsw.edu.au

Current Cancer Drug Targets
|March 12, 2009
PubMed

Insights

The Akt pathway is crucial for cancer cell survival and proliferation. Targeting this network, especially in prostate cancer, shows promise for overcoming chemoresistance and improving anti-tumour effects.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • The Akt pathway (also known as the Protein Kinase B or PKB network) plays a critical role in cancer cell survival and proliferation.
  • Dysregulation of the Akt network is implicated in the development and progression of various cancers.
  • Targeting the Akt network is a significant area of focus in cancer drug development.

Purpose of the Study:

  • To review key aspects of the Akt network.
  • To highlight the Akt network's role in prostate cancer biology.
  • To discuss therapeutic strategies targeting the Akt network.

Main Methods:

  • Literature review of Akt pathway research.
  • Analysis of clinical trial data for Akt-targeting agents.
  • Focus on Akt network's role in prostate cancer.

Main Results:

  • The Akt network is a central regulator of cancer cell survival and proliferation.
  • Numerous selective agents targeting the Akt pathway are in clinical trials.
  • Combination or sequential targeting strategies may enhance anti-tumour efficacy and overcome chemoresistance.

Conclusions:

  • The Akt network is a vital therapeutic target in oncology.
  • Targeting the Akt network, particularly in prostate cancer, offers potential for improved treatment outcomes.
  • Overcoming chemoresistance through multi-targeted approaches involving the Akt network is a promising strategy.

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...